+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Serotonergic Control of Oxytocin Release during Suckling in the Rat: Opposite Effects in Conscious and Anesthetized Rats



      S. Karger AG

      Serotonin, Oxytocinergic neurons, Oxytocin release, Suckling

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Serotonergic control over the reflex oxytocin (OT) release was investigated in anesthetized rats and in conscious rats. The effects of drugs were tested in the first case, on the electrical activity of oxytocinergic cells during suckling and in the second case, on the litter weight gain after 30 min suckling (indirect index of OT release). In rats anesthetized with urethane (1.2 g/kg), intraventricular injection of 1 μg serotonin interrupted the regular pattern of the neurosecretory bursts and milk ejections for about 15-20 min (inhibitory effect of the ‘all-or-none’ type). 10 μg cy-proheptadine or R47465 (serotonergic antagonists) slightly but significantly decreased the mean delay between two neurosecretory bursts without modifying their amplitude and in half the cases, disturbed their periodicity with occasional appearance of very close dual neurosecretory bursts. Pretreatment with p-chlorophenylalanine (PCPA) (250 mg/kg i.p.) did not prevent or affect the regular milk ejection pattern. The inhibitory effect of 5-HT was lengthened by fluoxetine, a 5-HT reuptake inhibitor (1 μl of 10-<sup>4</sup> M solution into the 3rd ventricle) and prevented by 5 μg R47465. In conscious rats, all the above drugs had an opposite effect. 5-HT and 5-HTP (5-HT precursor) did not affect the milk ejection reflex, whereas serotonergic antagonists and PCPA had an inhibitory effect. Injecting 5-HTP into the PCPA-treat-ed mothers restored their ability to release OT in response to suckling. Hypotheses for these opposite effects are discussed.

          Related collections

          Author and article information

          S. Karger AG
          26 March 2008
          : 36
          : 4
          : 300-306
          Laboratoire de Physiologie générale (LA 309 CNRS), Université Louis Pasteur, Strasbourg, France
          123471 Neuroendocrinology 1983;36:300–306
          © 1983 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 7
          Original Paper


          Comment on this article